Rb. Rothman et al., THE LIGAND-SELECTIVITY OF CLONED HUMAN AND RAT OPIATE MU-RECEPTORS STUDIED WITH [I-125]IOXY-AGO, Regulatory peptides, 54(1), 1994, pp. 249-250
The recent molecular cloning of mu, delta and kappa opiate receptors (
1-5) has created new opportunities for the study of opiate receptors.
The recent cloning of the human mu receptor (6) has shown that there i
s a high homology between the predicted human and rat mu receptor sequ
ences, but also some differences in sequence. We therefore sought sign
ificant changes in the ligand-selectivity profile of these two recepto
rs expressed in the COS and CHO cell lines under identical assay condi
tions. We used the novel agonist ligand [I-125]IOXY-AGO (6 beta-[(125)
Iodo]-3,14-dihydroxy-17-methyl-4,5 alpha-epoxymorphinan) since its hig
h specific activity (2200 Ci/mmol) and high affinity for mu opioid rec
eptors generated a high signal-to-noise ratio with use of relatively f
ew expressing cells. (7). The results indicate substantial similaritie
s in ligand-selectivity profile of the human and rat mu receptors, but
also modest differences.